334 related articles for article (PubMed ID: 17848394)
1. Impact of ENPP1 genotype on arterial calcification in patients with end-stage renal failure.
Eller P; Hochegger K; Feuchtner GM; Zitt E; Tancevski I; Ritsch A; Kronenberg F; Rosenkranz AR; Patsch JR; Mayer G
Nephrol Dial Transplant; 2008 Jan; 23(1):321-7. PubMed ID: 17848394
[TBL] [Abstract][Full Text] [Related]
2. Mutations in ENPP1 are associated with 'idiopathic' infantile arterial calcification.
Rutsch F; Ruf N; Vaingankar S; Toliat MR; Suk A; Höhne W; Schauer G; Lehmann M; Roscioli T; Schnabel D; Epplen JT; Knisely A; Superti-Furga A; McGill J; Filippone M; Sinaiko AR; Vallance H; Hinrichs B; Smith W; Ferre M; Terkeltaub R; Nürnberg P
Nat Genet; 2003 Aug; 34(4):379-81. PubMed ID: 12881724
[TBL] [Abstract][Full Text] [Related]
3. Association of ENPP1 (PC-1) K121Q polymorphism with obesity-related parameters in subjects with metabolic syndrome.
González-Sánchez JL; Zabena C; Martínez-Larrad MT; Martínez-Calatrava MJ; Pérez-Barba M; Serrano-Ríos M
Clin Endocrinol (Oxf); 2008 May; 68(5):724-9. PubMed ID: 17986276
[TBL] [Abstract][Full Text] [Related]
4. ENPP1 K121Q Genotype Not Associated with Coronary Artery Calcification in Korean Patients with Type 2 Diabetes Mellitus.
Jeong DJ; Lee DG; Kim HJ; Cho EH; Kim SW
Korean Diabetes J; 2010 Oct; 34(5):320-6. PubMed ID: 21076580
[TBL] [Abstract][Full Text] [Related]
5. The mutational spectrum of ENPP1 as arising after the analysis of 23 unrelated patients with generalized arterial calcification of infancy (GACI).
Ruf N; Uhlenberg B; Terkeltaub R; Nürnberg P; Rutsch F
Hum Mutat; 2005 Jan; 25(1):98. PubMed ID: 15605415
[TBL] [Abstract][Full Text] [Related]
6. The association of PC-1 (ENPP1) K121Q polymorphism with metabolic syndrome in patients with coronary heart disease.
Tasic I; Milojkovic M; Sunder-Plassmann R; Lazarevic G; Tasic NM; Stefanovic V
Clin Chim Acta; 2007 Feb; 377(1-2):237-42. PubMed ID: 17129580
[TBL] [Abstract][Full Text] [Related]
7. New polymorphism of ENPP1 (PC-1) is associated with increased risk of type 2 diabetes among obese individuals.
Bochenski J; Placha G; Wanic K; Malecki M; Sieradzki J; Warram JH; Krolewski AS
Diabetes; 2006 Sep; 55(9):2626-30. PubMed ID: 16936213
[TBL] [Abstract][Full Text] [Related]
8. Impact of ENPP1 and MMP3 gene polymorphisms on aortic calcification in patients with type 2 diabetes in a Korean population.
Lee JE; Choi YK; Seo HA; Jeon JH; Jeong JY; Moon SS; Kim JG; Kim BW; Kim SW; Min Yoo ; Kim JY; Lee IK
Diabetes Res Clin Pract; 2010 Apr; 88(1):87-96. PubMed ID: 20092902
[TBL] [Abstract][Full Text] [Related]
9. Novel inhibitors of alkaline phosphatase suppress vascular smooth muscle cell calcification.
Narisawa S; Harmey D; Yadav MC; O'Neill WC; Hoylaerts MF; Millán JL
J Bone Miner Res; 2007 Nov; 22(11):1700-10. PubMed ID: 17638573
[TBL] [Abstract][Full Text] [Related]
10. Does coronary artery calcification in patients with diabetic nephropathy depend on the advancement of renal failure?
Krzanowski M; Kuśnierz-Cabala B; Miarka P; Wójcik K; Stompór T; Sułowicz W
Med Pregl; 2007; 60 Suppl 2():39-42. PubMed ID: 18928155
[TBL] [Abstract][Full Text] [Related]
11. Arterial calcification is driven by RAGE in Enpp1-/- mice.
Cecil DL; Terkeltaub RA
J Vasc Res; 2011; 48(3):227-35. PubMed ID: 21099228
[TBL] [Abstract][Full Text] [Related]
12. New variants in the Enpp1 and Ptpn6 genes cause low BMD, crystal-related arthropathy, and vascular calcification.
Babij P; Roudier M; Graves T; Han CY; Chhoa M; Li CM; Juan T; Morony S; Grisanti M; Li X; Yu L; Dwyer D; Lloyd DJ; Bass MB; Richards WG; Ebeling C; Amato J; Carlson G
J Bone Miner Res; 2009 Sep; 24(9):1552-64. PubMed ID: 19419305
[TBL] [Abstract][Full Text] [Related]
13. Influence of interleukin-6 G-174C gene polymorphism on coronary artery disease, cardiovascular complications and mortality in dialysis patients.
Aker S; Bantis C; Reis P; Kuhr N; Schwandt C; Grabensee B; Heering P; Ivens K
Nephrol Dial Transplant; 2009 Sep; 24(9):2847-51. PubMed ID: 19349293
[TBL] [Abstract][Full Text] [Related]
14. ENPP1 gene, insulin resistance and related clinical outcomes.
Bacci S; De Cosmo S; Prudente S; Trischitta V
Curr Opin Clin Nutr Metab Care; 2007 Jul; 10(4):403-9. PubMed ID: 17563456
[TBL] [Abstract][Full Text] [Related]
15. The K121Q polymorphism of ENPP1 and peripheral arterial disease.
Eller P; Schgoer W; Mueller T; Tancevski I; Demetz E; Duwensee K; Ritsch A; Haltmayer M; Patsch JR
Heart Vessels; 2008 Mar; 23(2):104-7. PubMed ID: 18389334
[TBL] [Abstract][Full Text] [Related]
16. Effects of etidronate on the Enpp1⁻/⁻ mouse model of generalized arterial calcification of infancy.
Huesa C; Staines KA; Millán JL; MacRae VE
Int J Mol Med; 2015 Jul; 36(1):159-65. PubMed ID: 25975272
[TBL] [Abstract][Full Text] [Related]
17. Levels of serum ecto-nucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) predicts severity of abdominal aortic calcification in end-stage renal disease patients receiving regular dialysis.
Wu X; Di F; Shen S; Wang S; Li Q; Dong Z; Guan J; He J; Wang Y
Hemodial Int; 2022 Jan; 26(1):23-29. PubMed ID: 34235847
[TBL] [Abstract][Full Text] [Related]
18. Progressive vascular calcification over 2 years is associated with arterial stiffening and increased mortality in patients with stages 4 and 5 chronic kidney disease.
Sigrist MK; Taal MW; Bungay P; McIntyre CW
Clin J Am Soc Nephrol; 2007 Nov; 2(6):1241-8. PubMed ID: 17928470
[TBL] [Abstract][Full Text] [Related]
19. Association of the ENPP1 K121Q polymorphism with type 2 diabetes and obesity in the Moroccan population.
El Achhab Y; Meyre D; Bouatia-Naji N; Berraho M; Deweirder M; Vatin V; Delplanque J; Serhier Z; Lyoussi B; Nejjari C; Froguel P; Chikri M
Diabetes Metab; 2009 Feb; 35(1):37-42. PubMed ID: 19046915
[TBL] [Abstract][Full Text] [Related]
20. Genetic and enzymatic analysis for two Japanese patients with idiopathic infantile arterial calcification.
Numakura C; Yamada M; Ariyasu D; Maesaka A; Kobayashi H; Nishimura G; Ikeda M; Hasegawa Y
J Bone Miner Metab; 2006; 24(1):48-52. PubMed ID: 16369898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
